Canceled Vaccine May Have Boosted HIV Risk.

The article reports on evidence which has emerged which suggests that Merck & Co.'s experimental HIV vaccine may have made its recipients more vulnerable to the deadly AIDS virus. The evidence has prompted researchers to warn participants in other trials that similarly made vaccines for a range of other diseases might also increase their susceptibility to HIV. The impact the evidence may have on further vaccine research is discussed.